Format

Send to

Choose Destination
Nat Rev Microbiol. 2010 Sep;8(9):668-74. doi: 10.1038/nrmicro2387. Epub 2010 Aug 2.

Evasion of innate immunity by Mycobacterium tuberculosis: is death an exit strategy?

Author information

1
Division of Rheumatology, Immunology, and Allergy, Department of Medicine, Brigham and Womens Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA. sbehar@rics.bwh.harvard.edu

Abstract

Virulent Mycobacterium tuberculosis inhibits apoptosis and triggers necrosis of host macrophages to evade innate immunity and delay the initiation of adaptive immunity. By contrast, attenuated M. tuberculosis induces macrophage apoptosis, an innate defence mechanism that reduces bacterial viability. In this Opinion article, we describe how virulent M. tuberculosis blocks production of the eicosanoid lipid mediator prostaglandin E(2) (PGE(2)). PGE(2) production by infected macrophages prevents mitochondrial damage and initiates plasma membrane repair, two processes that are crucial for preventing necrosis and inducing apoptosis. Thus, M. tuberculosis-mediated modulation of eicosanoid production determines the death modality of the infected macrophage, which in turn has a substantial impact on the outcome of infection.

PMID:
20676146
PMCID:
PMC3221965
DOI:
10.1038/nrmicro2387
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for PubMed Central
Loading ...
Support Center